These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 7844217)

  • 21. Do younger women with elevated basal follicular stimulating hormone levels undergoing gonadotropin-stimulated intrauterine insemination cycles represent compromised reproductive outcomes?
    Devranoğlu B; Özdamar Ö; Köle E; Eken MK; Bozdağ H; Doğer E
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():141-5. PubMed ID: 26930042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of GnRH agonist trigger in women having history of follicular-endometrial asynchrony with clomiphene/IUI cycles in unexplained infertility.
    Bathwal S; Chakravarty A; Sharma S; Singh S; Saha I; Chakravarty B
    Arch Gynecol Obstet; 2018 Aug; 298(2):427-432. PubMed ID: 29955952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of pre-ovulatory gonadotrophin surge with gonadotrophin-releasing hormone agonist compared to pre-ovulatory injection of human chorionic gonadotrophins for ovulation induction in intrauterine insemination treatment cycles.
    Shalev E; Geslevich Y; Matilsky M; Ben-Ami M
    Hum Reprod; 1995 Sep; 10(9):2244-7. PubMed ID: 8530644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
    Kabli N; Sylvestre C; Tulandi T; Buckett W
    Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian response in consecutive cycles of ovarian stimulation in normally ovulating women.
    Ahmed Ebbiary NA; Morgan C; Martin K; Afnan M; Newton JR
    Hum Reprod; 1995 Mar; 10(3):536-43. PubMed ID: 7782429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial.
    Berker B; Kahraman K; Taskin S; Sukur YE; Sonmezer M; Atabekoglu CS
    Arch Gynecol Obstet; 2011 Dec; 284(6):1561-6. PubMed ID: 21773781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. 'Effective treatment' or 'not a natural choice'?
    Hughes EG
    Hum Reprod; 2003 May; 18(5):912-4. PubMed ID: 12721161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous LH surge versus hCG as ovulation trigger after low-dose highly purified FSH in IUI: a comparison of 761 cycles.
    Romeu A; Monzó A; Peiró T; Diez E; Peinado JA; Quintero LA
    J Assist Reprod Genet; 1997 Oct; 14(9):518-24. PubMed ID: 9401870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic,chronic anovulation: a prospective randomized study.
    Yarali H; Bukulmez O; Gurgan T
    Fertil Steril; 1999 Aug; 72(2):276-81. PubMed ID: 10438995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
    van Santbrink EJ; Fauser BC
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting and optimizing success in an intra-uterine insemination programme.
    Plosker SM; Jacobson W; Amato P
    Hum Reprod; 1994 Nov; 9(11):2014-21. PubMed ID: 7868666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clomiphene Citrate versus Recombinant FSH in intrauterine insemination cycles with mono- or bi-follicular development.
    Tokgoz VY; Sukur YE; Ozmen B; Sonmezer M; Berker B; Aytac R; Atabekoglu CS
    JBRA Assist Reprod; 2021 Jul; 25(3):383-389. PubMed ID: 33746515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial.
    Azmoodeh A; Pejman Manesh M; Akbari Asbagh F; Ghaseminejad A; Hamzehgardeshi Z
    Glob J Health Sci; 2015 Sep; 8(4):244-52. PubMed ID: 26573024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Women with ovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate for intrauterine insemination may benefit from administration of human chorionic gonadotropin.
    Vlahos NF; Coker L; Lawler C; Zhao Y; Bankowski B; Wallach EE
    Fertil Steril; 2005 May; 83(5):1510-6. PubMed ID: 15866592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination.
    Dickey RP; Taylor SN; Lu PY; Sartor BM; Rye PH; Pyrzak R
    Fertil Steril; 2002 Nov; 78(5):1088-95. PubMed ID: 12413999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu.
    Cassidenti DL; Paulson RJ; Lobo RA; Sauer MV
    Hum Reprod; 1992 Mar; 7(3):344-8. PubMed ID: 1587939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.
    Bedaiwy MA; Forman R; Mousa NA; Al Inany HG; Casper RF
    Hum Reprod; 2006 Nov; 21(11):2838-44. PubMed ID: 16877370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.